OR WAIT null SECS
August 04, 2022
Pharma companies may benefit from meeting challenges and embracing small molecule drug discovery.
August 03, 2022
Dr. Kyle Flanigan, Ph.D., discusses the benefits of an oral COVID-19 vaccine.
July 27, 2022
Has data science finally reached a level playing field with all of the science data being uncovered in the make, test, decide innovation cycle?
July 11, 2022
Kobel discusses taking a company public during a challenging time in the market.
July 07, 2022
Amidst lack of funding for women’s health research, industry must collaborate now to advance RMMH.
June 29, 2022
As director of corporate strategy for Novartis, Kamenska defines direction for the company’s overall enterprise. Here, she discusses how the pandemic and recent market events are shaping these strategies.
June 15, 2022
Larger pipeline and increased support from regulatory authorities are setting up the orphan drug market for long-term success.
June 14, 2022
Industry must continue research and development to combat the pandemic.
June 13, 2022
Makar discusses the significance of AstraZeneca’s diabetes and heart failure drug Forxiga (dapagliflozin) for the treatment of chronic kidney disease (CKD).
June 08, 2022
Survey taken by pharma and CRO executives evaluates how effectively various programs convert RWD into usable data.
